Dipanjan Chowdhury

No ORCID on file · 4 papers in corpus
other 2026
Scientific reports ·doi:10.1038/s41598-026-45020-3

Hereditary breast and ovarian cancer syndrome (HBOC) is principally caused by germline mutations in BRCA1 and BRCA2. However, most women with HBOC are undiagnosed, and some patients meeting clinical criteria for HBOC will have no identifiab…

diagnostic-accuracy 2024
Gynecologic Oncology ·doi:10.1016/j.ygyno.2024.08.008

OBJECTIVE: To determine whether a multimodal assay combining serum microRNA with protein biomarkers and metadata improves triage assessment of an adnexal mass. METHODS: Serum samples from 468 training subjects (191 cancer cases and 277 ben…

other 2020
BMC genomics ·doi:10.1186/s12864-020-6530-3

BACKGROUND: The consensus on how to choose a reference gene for serum or plasma miRNA expression qPCR studies has not been reached and none of the potential candidates have yet been convincingly validated. We proposed a new in silico approa…

other 2017
Oncoimmunology ·doi:10.1080/2162402x.2016.1277308

Clear cell ovarian carcinoma (CCOC) represents a distinct histologic subtype of ovarian cancer associated with significantly worse prognosis across all stages and no effective therapeutic options. Here, we report a rare but clinically impor…